Results 11 to 20 of about 868 (155)

A Clinical Trial of The Evaluation of Environmental Exposure in Yttrium 90 Radioembolization [PDF]

Sakarya Üniversitesi Fen Bilimleri Enstitüsü Dergisi, 2018
Aim: The aim of this study is to measure the dose rate of twodifferent forms of Y-90 microsphere used for radioembolization and to evaluatethe results according to radiation safety regularities.
Handan Tanyildizi, İffet Çavdar, Mustafa Demir   +2 more
doaj   +2 more sources

Y-90 microshperes in the treatment of unresectable hepatocellular carcinoma

The Saudi Journal of Gastroenterology, 2008
A small percentage of patients with hepatocellular carcinoma (HCC) are candidates for curative treatment in form of resection or transplantation. There are different treatment options for unresectable HCC-like local ablative therapies and recently ...
Al-Kalbani Abdullah, Kamel Yasser
doaj   +1 more source

Measure of ⁹⁰Y-glass microspheres residue post-TARE using PET/CT and potential impact on tumor absorbed dose in comparison ^99mTc-MAA SPECT/CT dosimetry. [PDF]

EJNMMI Rep
Transarterial radio-embolization (TARE) became a routine procedure for non-resectable liver tumor mainly hepatocellular carcinoma (HCC). Personalized dosimetry to the index lesion increased tumor response rate. However, there is no requirement to measure
Boughdad S, Duran R, Prior JO, da Mota M, De Carvalho MM, Costes J, Firsova M, Gnesin S, Schaefer N.   +8 more
europepmc   +2 more sources

Abstract No. 545 Factors affecting residual catheter hub radioactivity during intrahepatic delivery of 90 Y TheraSphere [PDF]

Journal of Vascular and Interventional Radiology, 2018
P. Massa, M. Pilat, N. Bevins, M. Vanderhoek, S. Schwartz, T. Getzen   +5 more
openaire   +2 more sources

AAPM Medical Physics Practice Guideline 14.a: Yttrium-90 microsphere radioembolization. [PDF]

J Appl Clin Med Phys
Abstract Radioembolization using Yttrium‐90 (90Y) microspheres is widely used to treat primary and metastatic liver tumors. The present work provides minimum practice guidelines for establishing and supporting such a program. Medical physicists play a key role in patient and staff safety during these procedures.
Busse NC, Al-Ghazi MSAL, Abi-Jaoudeh N, Alvarez D, Ayan AS, Chen E, Chuong MD, Dezarn WA, Enger SA, Graves SA, Hobbs RF, Jafari ME, Kim SP, Maughan NM, Polemi AM, Stickel JR.   +15 more
europepmc   +2 more sources

Reimbursement of interventional oncology in Australia: How it works and how it does not

Journal of Medical Imaging and Radiation Oncology, Volume 67, Issue 8, Page 915-925, December 2023., 2023
Summary The practice of interventional oncology (IO) embodies all the qualities that one would expect to find in a modern, value‐based healthcare system. A dynamic, cutting‐edge specialty like IO uses highly‐targeted, minimally‐invasive, image‐guided techniques to deliver cost‐effective, personalised medicine for cancer patients.
Nicholas Brown
wiley   +1 more source

Clinically Translatable Phosphonated Silica Microspheres for Selective Internal Radiation Therapy of Hepatocellular Carcinoma

Small Science, Volume 3, Issue 10, October 2023., 2023
Phosphonated silica microspheres (PSM) are prepared by a facile method to be radiolabeled with 177Lu in a rapid and effective manner. The prepared 177Lu‐PSM exhibits excellent antitumor activity and SPECT/CT imaging capability, which indicate that 177Lu‐PSM might hold considerable potential for translation to clinical applications.
Yi Zhou, Jianxian Ge, Yun Gao, Zhe Yang, Mohammad Javad Afshari, Can Chen, Manran Wu, Lei Chen, Shuwang Wu, Guangxin Duan, Jianfeng Zeng, Mingyuan Gao   +11 more
wiley   +1 more source

Radioactive Microspheres for Selective Internal Radiation Therapy of Hepatocellular Carcinoma

Advanced NanoBiomed Research, Volume 3, Issue 6, June 2023., 2023
This review focuses on radioactive microspheres by elaborating the recent achievements from a comprehensive view of facile preparation, biodegradability, and multifunction and summarizes the challenges the radioactive microspheres are facing in selective internal radiation therapy of hepatocellular carcinoma. Selective internal radiation therapy (SIRT)
Yi Zhou, Yun Gao, Guangxin Duan, Ling Wen, Shanshan Shan, Shuwang Wu, Jianfeng Zeng, Mingyuan Gao   +7 more
wiley   +1 more source

TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis

Cancer Medicine, Volume 12, Issue 3, Page 2590-2599, February 2023., 2023
In this overall and individual level meta‐analysis, patients with hepatocellular carcinoma treated with transarterial chemoembolization and transarterial radioembolization (TARE) showed similar survival. Patients treated with TARE however, had a longer time to tumor progression. Abstract Background Transarterial radioembolization (TARE) is increasingly
Andrew M. Brown, Ihab Kassab, Marco Massani, Whitney Townsend, Amit G. Singal, Cigdem Soydal, Laura Moreno‐Luna, Lewis R. Roberts, Vincent L. Chen, Neehar D. Parikh   +9 more
wiley   +1 more source

A critical review of bioactive glasses and glass–ceramics in cancer therapy

International Journal of Applied Glass Science, Volume 14, Issue 1, Page 69-87, January 2023., 2023
Abstract There is an ongoing profound shift in using glass as a primarily passive material to one that instills active properties. We believe and demonstrate that bioactive glasses (BGs) and glass–ceramics (BGCs) as functional biomaterials for cancer therapy can transform the world of healthcare in the 21st century.
Ali Moeini, Turan Hassanzadeh Chinijani, Adrine Malek Khachatourian, Marcus Vinicius Lia Fook, Francesco Baino, Maziar Montazerian   +5 more
wiley   +1 more source